Related Articles
Preoperative serum tissue factor pathway inhibitor‑2 level as a prognostic marker for endometrial cancer
Tissue factor pathway inhibitor 2 as a serum marker for diagnosing asymptomatic venous thromboembolism in patients with epithelial ovarian cancer and positive D‑dimer results
Survival and biomarker analysis for cancer‑associated thromboembolism in ovarian clear cell carcinoma
Prognostic significance of the number of removed lymph nodes according to FIGO stage in ovarian clear cell carcinoma
Prognostic value of fibrinogen‑to‑albumin ratio in patients with gastric cancer receiving first‑line chemotherapy